Park Place Capital Corp Immunocore Holdings PLC Transaction History
Park Place Capital Corp
- $291 Million
- Q2 2024
A detailed history of Park Place Capital Corp transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Park Place Capital Corp holds 29 shares of IMCR stock, worth $902. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 29
-0.0%
Holding current value
$902
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$199 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$152 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$93.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.2 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$60.7 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.37B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...